Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1992-02-24
1993-11-30
Zitomer, Stephanie W.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 935 77, 935 78, 536 231, C12Q 168, C07H 1512
Patent
active
052664597
ABSTRACT:
A method for detecting a new Gaucher disease mutation in an allele in a human having a point mutation of an adenine nucleotide substituted for a guanine nucleotide at nucleotide position 1 in the normal glucocerebrosidase gene intron 2 is provided. Identification of the mutation is accomplished by first amplifying, with a polymerase chain reaction (PCR) primer, a region of human genomic DNA containing nucleotide position 1 of glucocerebrosidase gene intron 2 followed by detection of the mutation.
REFERENCES:
Dahl et al., "Gaucher Disease Type III (Norrbottnian Type) is Caused by a Single Mutation in Exon 10 of the Glucocerebrosidase Gene", Am. J. Hum. Genet., 47:275-278 (1990).
Beutler et al., "The Facile Detection of the nt 1226 Mutation of Glucocerebrosidase by `Mismatched` PCR", Clin. Chim. Acta., 194:161-166 (1990).
Beutler, "Goucher's Disease", New Engl. J. Med., 325:1354-1359 (1991).
Beutler et al., "Identification of the Second Common Jewish Gaucher Disease Mutation Makes Possible Population-based Screening for the Heterozygous State", Proc. Natl. Acad. Sci., USA, 88:10544-10547 (1991).
Hong et al., "Sequence of Two Alleles Responsible for Gaucher Disease", DNA and Cell Biol., 9:233-241 (1990).
Horowitz et al., "The Human Glucocerebrosidase Gene and Pseudogene: Structure and Evolution", Genomics, 4:87-96 (1989).
Kumar et al., "Designed Diagnostic Restriction Fragment Length Polymorphisms for the Detection of Point Mutations in ras Oncogenes", Oncogene Res., 1:235-241 (1989).
Latham et al., "Heterogeneity of Mutations in the Acid .beta.-Glucosidase Gene of Gaucher Disease Patients", DNA and Cell Biol., 10:15-21 (1991).
Sorge et al., "Molecular Cloning and Nucleotide Sequence of Human Glucocerebrosidase cDNA", Proc. Natl. Acad. Sci., USA, 82:7289-7293 (1985).
Sorge et al., "The Human Glucocerebrosidase Gene Has Two Functional ATG Initiator Codons", Am. J. Hum. Genet., 41:1016-1024 (1987).
Sorge et al., "High Level Transcription of the Glucocerebrosidase Pseudogene in Normal Subjects and Patients with Gaucher Disease", J. Clin. Invest., 86:1137-1141 (1990).
Theophilus et al., "Gaucher Disease: Molecular Heterogeneity and Phenotype-Genotype Correlations", Am. J. Hum. Genet., 45:212-225 (1989).
Tsuji et al., "A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's Disease", New Engl. J. Med., 316:570-575 (1987).
Tsuji et al., "Genetic Heterogeneity in Type 1 Gaucher Disease: Multiple Genotypes in Ashkenazic and Non-Ashkenazic Individuals", Proc. Natl. Acad. Sci., USA, 85:2349-2352 (1988).
Zimran et al., "Prediction of Severity of Gaucher's Disease by Identification of Mutations at DNA Level", The Lancet, 2:349-352 (1989).
Zimran et al., "A Glucocerebrosidase Fusion Gene in Gaucher Disease", J. Clin. Invest., 85:219-222 (1990).
Bingham Douglas A.
Fitting Thomas
Logan April C.
The Scripps Research Institute
Zitomer Stephanie W.
LandOfFree
Gaucher's disease: detection of a new mutation in intron 2 of th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gaucher's disease: detection of a new mutation in intron 2 of th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gaucher's disease: detection of a new mutation in intron 2 of th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2094998